NASDAQ:SILO Silo Pharma Q3 2026 Earnings Results & Report $1.67 +0.10 (+6.29%) As of 10:55 AM Eastern This is a fair market value price provided by Massive. Learn more. Silo Pharma beat analyst earnings expectations in its Q3 2026 results, released November 13, 2026. The company reported EPS of -$0.21 versus the -$4.80 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 13, 2026TimeAfter Market Closes Silo Pharma EPS ResultsActual EPS-$0.21Consensus EPS -$4.80Beat/MissBeat by +$4.59One Year Ago EPSN/ASilo Pharma Revenue ResultsActual RevenueN/AExpected Revenue$18 thousandBeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsSilo Pharma's next earnings date is estimated for Wednesday, December 2, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Silo Pharma Q3 2026 Earnings FAQ Did Silo Pharma beat earnings estimates for Q3 2026? Silo Pharma (NASDAQ:SILO) reported earnings of -$0.21 per share for Q3 2026, beating the consensus estimate of -$4.80. The report was announced on Friday, November 13, 2026. When is Silo Pharma's next earnings date? Silo Pharma's next earnings date is estimated for Wednesday, December 2, 2026. MarketBeat tracks confirmed and estimated earnings dates for Silo Pharma on the company's earnings history page. Silo Pharma Earnings HeadlinesSilo Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 14 at 5:12 PM | marketscreener.comMSilo Pharma Acquires Software Assets Through Equity IssuanceOctober 14, 2026 | tipranks.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.November 17 at 1:00 AM | Weiss Ratings (Ad)Silo Pharma’s QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime FlexibilitySeptember 30, 2026 | markets.businessinsider.comSilo Pharma's QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime FlexibilitySeptember 30, 2026 | globenewswire.comSilo Pharma Gets U.S. Patent Allowance For SPC-15 PTSD TreatmentSeptember 18, 2026 | rttnews.comSee More Silo Pharma Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Silo Pharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Silo Pharma and other key companies, straight to your email. Email Address About Silo PharmaSilo Pharma (NASDAQ:SILO) is a development-stage biopharmaceutical company focused on treatments for central nervous system disorders and pain conditions. Its research programs include potential therapies for post-traumatic stress disorder, Alzheimer’s disease and chronic pain. The company works on drug candidates and delivery approaches involving compounds such as ketamine, including formulations intended to support targeted or sustained treatment. Silo’s programs remain in development, and the company does not have a marketed product.View Silo Pharma ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its YearThe Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to WatchTyson Foods' Earnings Beat Hides a Warning for Consumer Staples Dividend InvestorsMongoDB's Biggest Advantage May Be GitLab's Biggest WeaknessMicrosoft's Outage Barely Moved Its Stock, But a Bigger Risk May Be BuildingTyson Foods' 10% Surge Puts a Breakout in Sight, But Wall Street Remains CautiousOndas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog? Upcoming Earnings Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.